Abstract
Background
Positron emission tomography (PET)/computed tomography (CT) is a new imaging modality that provides exact coregistration of anatomic and metabolic data. We have investigated to what degree this new technique might affect the interpretation of PET images in a nonselected group of consecutive cancer patients, reflecting routine condition in a busy cancer center.
Methods
Whole-body 2-deoxy-2-[F-18]fluoro-d-glucose (FDG)–PET and PET/CT fusion image sets were compared in 100 consecutive, nonselected patients: 21 with head and neck cancer, 39 with chest malignancies, and 40 with malignancies of the abdomen and pelvis. All studies were performed for primary staging or evaluation of therapy and were interpreted by two nuclear medicine physicians also trained in radiology. Areas of abnormal FDG uptake were identified on PET and graded as likely benign, equivocal, or likely malignant. Positron emission tomography/computed tomography fusion images were then made available, and the initial findings were amended if necessary.
Results
One hundred sixty-six areas with abnormal FDG uptake were identified. Based on PET alone, 51 sites were considered equivocal for malignancy. With PET/CT, the number of equivocal lesions decreased to 24. This difference is more marked in the head and neck as well as the abdomen and pelvis. When the equivocal sites were included in the analysis and grouped with the malignant sites, positive predictive value (PPV) of PET/CT was 89% compared with 75% for PET (p = 0.04).
Conclusion
Combined PET/CT results in increased reader confidence and 53% fewer equivocal readings, as well as improved PPV compared with PET alone.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
R Hustinx F Benard A Alavi (2002) ArticleTitleWhole-body FDG-PET imaging in the management of patients with cancer Semin Nucl Med 32 35–46 Occurrence Handle11839068
JB Bomanji DC Costa PJ Ell (2001) ArticleTitleClinical role of positron emission tomography in oncology Lancet Oncol 2 157–164 Occurrence Handle10.1016/S1470-2045(00)00257-6 Occurrence Handle1:STN:280:DC%2BD387ntFeltg%3D%3D Occurrence Handle11902566
E Bombardieri I Carrio P Gonzalez et al. (1999) ArticleTitleCurrent applications and perspectives of diagnostic nuclear medicine in oncology. Task Group of Oncology Int J Oncol 14 877–890 Occurrence Handle1:STN:280:DyaK1M3hvVeltQ%3D%3D Occurrence Handle10200337
V Bettinardi E Pagani MC Gilardi et al. (1999) ArticleTitleAn automatic classification technique for attenuation correction in positron emission tomography Eur J Nucl Med 26 447–458 Occurrence Handle10.1007/s002590050410 Occurrence Handle1:STN:280:DyaK1MzhtFSqtA%3D%3D Occurrence Handle10382087
T Beyer DW Townsend T Brun et al. (2000) ArticleTitleA combined PET/CT scanner for clinical oncology J Nucl Med 41 1369–1379 Occurrence Handle1:STN:280:DC%2BD3cvitFCguw%3D%3D Occurrence Handle10945530
A Trojan M Jermann C Taverna TF Hany (2002) ArticleTitleFusion PET-CT imaging of neurolymphomatosis Ann Oncol 13 802–805 Occurrence Handle10.1093/annonc/mdf057 Occurrence Handle1:STN:280:DC%2BD38zjtlWqtA%3D%3D Occurrence Handle12075752
S Makhija N Howden R Edwards J Kelley DW Townsend CC Meltzer (2002) ArticleTitlePositron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: A retrospective review Gynecol Oncol 85 53–58 Occurrence Handle10.1006/gyno.2002.6606 Occurrence Handle1:STN:280:DC%2BD387pt1ejsQ%3D%3D Occurrence Handle11925120
P Kluetz C Meltzer V Villemagne et al. (2000) ArticleTitleCombined PET/CT imaging in oncology. Impact on patient management Clin Positron Imaging 3 223–230 Occurrence Handle10.1016/S1095-0397(01)00055-3 Occurrence Handle11378434
T Hany H Steinert G Goerres A Buck G Schulthess Particlevon (2002) ArticleTitlePET diagnostic accuracy: Improvement with in-line PET-CT system: Initial results Radiology 225 575–581
D Lardinois W Weder TF Hany et al. (2003) ArticleTitleStaging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography N Engl J Med 348 2500–2507 Occurrence Handle12815135
M Gonen KS Panageas SM Larson (2001) ArticleTitleStatistical issues in analysis of diagnostic imaging experiments with multiple observations per patient Radiology 221 763–767 Occurrence Handle1:STN:280:DC%2BD3Mnntlyjsw%3D%3D Occurrence Handle11719674
C Cohade M Osman Y Nakamoto et al. (2003) ArticleTitleInitial experience with oral contrast in PET/CT: Phantom and clinical studies J Nucl Med 44 412–416 Occurrence Handle12621008
GW Goerres E Kamel B Seifert et al. (2002) ArticleTitleAccuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET/CT system J Nucl Med 43 1469–1475 Occurrence Handle12411550
Author information
Authors and Affiliations
Corresponding author
Additional information
*Contributed equally to this work.
Rights and permissions
About this article
Cite this article
Yeung, H.W.D., Schöder, H., Smith, A. et al. Clinical Value of Combined Positron Emission Tomography/Computed Tomography Imaging in the Interpretation of 2-Deoxy-2-[F-18]fluoro-d-glucose–Positron Emission Tomography Studies in Cancer Patients. Mol Imaging Biol 7, 229–235 (2005). https://doi.org/10.1007/s11307-005-4113-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-005-4113-y